and if mucosa became sensitised IgA antibodies might be formed and inactivate the insulin. Hence the recent availability of human insulin, produced by DNA-recombinant techniques,9 appears to be more promising than porcine insulin.
Introduction
Hyposensitisation is effective in allergic rhinitis due to grasspoHen sensitivity,' 3 and a favourable response to this treatment has been associated with increased production of so-called blocking antibodies and IgE antibodies specific for grass pollen. failed to show a beneficial effect of hyposensitisation in asthma have been criticised on the grounds that bronchial reactivity to the allergen had not been demonstrated, the dose of allergen was inappropriate, or evidence of any immunological response to the treatment was lacking.
We have reported a deterioration in the asthma of children with grass-pollen bronchial reactivity during the grass-pollen season6 and now report on the value of hyposensitisation to rye-grass pollen in such children. We evaluated the efficacy of treatment by assessing clinical symptoms, drug usage, and specific IgE and IgG antibody responses.
Subjects and methods
We studied 13 boys and seven girls aged 9 to 14 years (median 11 years). They were selected as follows. A questionnaire was distributed at random to 1000 children in the Melbourne metropolitan area. A total of 600 responses were received, from which 58 children with a history of wheeze consistent with asthma were selected. They were admitted to hospital and subjected to bronchial provocation tests with allergens. The 20 children included here gave immediate reactions to an aqueous rye-pollen extract, 11 of them had a further reaction at six to eight hours. All patients gave a positive reaction to a skin-prick test with rye grass, and 18 were also sensitive to Dermatophagoides pteronyssinus and other antigens.
All 20 children had had a history of recurrent wheeze for at least three years, and 11 had wheezed since early childhood. In the year before the study all had suffered at least four episodes of wheezing for at least 72 hours both during and outside the grass pollen season; 10 patients had had more than seven episodes. All patients were under the care of their family doctor and nine used prophylactic asthma medication throughout the study (eight inhaled sodium cromoglycate and one beclomethasone dipropionate). The one patient using beclomethasone and three of those inhaling cromoglycate also inhaled nebulised bronchodilator solutions regularly. All other patients had used oral or aerosol bronchodilators intermittently in the year before the study and continued to use these medications throughout.
The purpose of the study was fully explained to both the children and their parents and informed consent obtained.
Four months before the trial the children were admitted to the Royal Children's Hospital, Melbourne, for bronchial provocation tests with rye-grass pollen extract and blood sampling. They were then allocated at random to receive either active treatment (n= 11) or a placebo (n = 9). Those given active treatment underwent rush 
METHODS
Daily pollen counts were obtained during the study with a Burkhardt spore trap, situated on the roof of a building 42 m above the ground in the centre of Melbourne. The technique of sampling and method of measuring daily grass-pollen counts have been described. 6 In this study daily grass-pollen counts were added together and reported as weekly counts.
IgE antibodies to rye-grass pollen extract were measured by the radioallergosorbent test7 and results expressed in arbitrary radioallergosorbent test units (units/ml), as recommended by Pharmacia Diagnostics, AB, Sweden.
IgG antibodies to the group I protein of rye-grass pollen were measured by a double-antibody-binding procedure essentially as described by Platts-Mills et al.8 All sera were assayed either in duplicate or triplicate to give a mean value, and binding activity was expressed in units calibrated against a standard serum.
Statistical analyses were performed with a Hewlett Packard 3000 computer at the Royal Children's Hospital using the Statistical Package for the Social Sciences (SPSS) program. Non-parametric tests were used throughout, and the null hypothesis was rejected when p < 005.
Results Figure 1 shows the basic design of the study together with the weekly grass-pollen counts during each season. Counts were lower and peaked later in the second year, but in both years the midpoint assessments coincided with times of high counts. treatment in the preceding four weeks were recorded for analysis at the completion of the study. A symptom score was calculated from: (a) the frequency ofwheezing, graded 0-3 (no wheeze (0), up to two episodes (1), four episodes (2), continuous wheeze (3)); (b) the number of days absent from school due to asthma; and (c) parental assessment of severity of asthma, assessed by one parent on a scale from 0 to 10 (0, no asthma; 10, severe asthma). A final symptom score was obtained by summation of (a), (b), and (c).
Sodium cromoglycate, theophylline, and sympathomimetic medication were scored according to the number of times they had been administered daily and beclomethasone dipropionate by the number seasonal influence on the cumulative clinical and drug scores of the patients was still apparent (table II) .
In When the clinical and immunological data obtained in the two years of the study were compared for both treatment groups there were no significant clinical differences at any time. The IgG antibody concentrations of the active-treatment group were significantly higher in the first year than in the second, both before (p < 0 05) and during (p < 002) the pollen season.
Discussion
In this small study we were unable to detect any beneficial influence on the clinical course of childhood asthma after hyposensitisation treatment with an aqueous rye-grass pollen preparation. All the patients had proved bronchial sensitivity to rye-grass pollen and most, regardless of which treatment they received, showed a deterioration in their asthma during the ryepollen season. Despite convincing in-vitro evidence that patients given hyposensitisation treatment developed increased concentrations of both specific IgG and IgE anti-rye antibodies compared with the patients given placebo injections, the natural seasonal exposure to the rye allergen appeared to override these changes.
Aas4 and Warner et a15 showed hyposensitisation to benefit children with asthma and proved bronchial reactivity to either house dust or D pteronyssinus allergens. Both studies reported clinical benefit and improved bronchial tolerance to the allergen. We could not compare either of these studies with the present investigation. Mite antigens are probably the most potent allergen in childhood asthma,9-"1 and though our patients had positive bronchial reactivity to rye-grass pollen, most of them were also sensitised to D pteronyssinus, as judged by skin-prick tests and serum IgE antibody measurements. All, however, showed a pronounced deterioration of their asthma in the pollen season, though from results of studiesl-3 on hyposensitisation in patients with seasonal rhinitis we had expected some clinical improvement from hyposensitisation treatment.
To try to overcome the problems associated with some hyposensitisation trials we included in our trial only patients with established bronchial reactivity; treatment and placebo groups were matched for age and clinical severity; and the hyposensitised patients received the maximal dose of allergen which could be tolerated. Furthermore, this dose of antigen was subsequently shown to induce significant concentrations of specific IgG antibody to the rye allergen. Though a beneficial "blocking" role for such antibodies is claimed to be effective in hay fever,2 12 recent studies suggest that these would not prevent access of allergen to sensitised mucosal mast cells.1' We found no evidence that development of IgG antibodies to grass pollen was of clinical benefit.
Though the children in this study did not benefit from hyposensitisation, we cannot discount the possibility that others with asthma due solely to grass-pollen sensitivity might benefit. Bronchial reactivity associated with such a restricted hypersensitivity is uncommon in Australian children. SHORT REPORTS Successful emergency transoesophageal cardiac pacing with subsequent endoscopy Transoesophageal cardiac pacing was described in 1969.1 Since the introduction of temporary transvenous pacing, however, it has not been used routinely in clinical practice. The recent introduction of a specially designed flexible electrode and pulse amplifier has allowed the technique to be used rapidly in asystolic patients before inserting an intracardiac pacemaker. The equipment and technique have been described. 2 The condition of the oesophagus using earlier equipment was assessed in necropsy studies on patients and dogs.1 3 We can find no record of the endoscopic appearances of the oesophagus after using the flexible electrode. We therefore report the successful use of transoesophageal pacing and describe the endoscopic findings both at two days and at two months.
Case report
A 71-year-old woman was admitted after feeling dizzy at home. Her general practitioner had recorded a pulse of 20 beats/min. She 
